Description of Research Expertise
Clinical trials in non-Hodgkin's lymphoma, phase I, II and III
Selected Publications
Hivnor CM, Nguyen V, Rook AH, Junkins-Hopkins J, Gelfand JM, Nasta S, Frank I, Kim EM: CD8+ lymphoma in a patient with human immunodeficiency virus Arch Dermatol 141 (10): 1321-2,2005.
Tsai DE, Aqui NA, Vogl DT, Bloom RD, Schuster SJ, Nasta SD, Wasik MA: Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene.
Am J Transplant 5 (8): 2070-3,2005.
Vogl DT, Glatstein E, Carver JR, Schuster SJ, Stadtmauer EA, Luger S, Nasta SD, Porter DL, Elstrom R, Tsai DE: Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.
Leuk Lymphoma. 46 (9): 1313-20,2005.
Loren AW, Luger SM, Stadtmauer EA, Tsai DE, Schuster S, Nasta SD, Goldstein SC, Perl A, Orloff G, Oliver JC, Green J, Emerson SG, Porter DL: Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.
Bone Marrow Transplantation 35 (9): 921-6,2005.
Tsai DE, Maillard I, Downs LH, Alavi A, Nasta SD, Glatstein E, Schuster SJ: Use of iodine 131I-tositumomab radioimmunotherapy in a patient with Waldenstrom's macroglobulinemia.
Leuk Lymphoma. 45 (3): 591-5,2004.
Nasta SD, Hoff PM, GeorgeCM, Neubauer, M, Cohen SC, Abbruzzese JA, Winn R., Pazdur RM: “Phase II Study of MGI-114 Administered Intravenously for Five Days Every 28 Days to Patients with Metastatic Colorectal Cancer” Am J Clin Oncol. 26 (2): 132-4,2003.
Nasta SD, Carrum G., Shahab I., Hanania N, Udden MM: “Regression of a Plasmablastic Lymphoma in a Patient with HIV on Highly Active Antiretroviral Therapy” Leuk Lymphoma 43 (2): 423-426,2002.
Cohen AD, Luger SM, Sickles C, Mangan PA, Porter DL, Schuster SJ, Tsai DE, Nasta S, Gewirtz AM, Stadtmauer EA: “ Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease" Bone Marrow Transplant 30 (1): 23-28,2002.
Dwivedy, S: “Hodgkin’s Disease: Clinical Management and Future Perspectives” Fellows Reporter 6 (3): 2001.
Dwivedy S, . Hoff P. M, Dumas P., . Lassere Y, . Aguayo A, . Hayakawa T, Abbruzzese J.L.: Safety and phamacokinetics (PK) of an antitumor/antiangiogenic agent, TAS-102: a phase I study for patients(pts) with solid tumors ASCO : 2001.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-159
3400 Civic Center Boulevard
Philadelphia,
PA
19104
Phone: (215) 662-3933
Patient appointments: 800-789-7366